Korovesis Theofanis George, Koutrolou-Sotiropoulou Paraskevi, Katritsis Demosthenes George
Department of Cardiology, Hygeia Hospital, Athens, Greece.
Arrhythm Electrophysiol Rev. 2022 Apr;11:e16. doi: 10.15420/aer.2021.28.
Mitral valve prolapse (MVP) is a common condition present in 1-3% of the population. There has been evidence that a subset of MVP patients is at higher risk of sudden cardiac death. The arrhythmogenic mechanism is related to fibrotic changes in the papillary muscles caused by the prolapsing valve. ECG features include ST-segment depression, T wave inversion or biphasic T waves in inferior leads, and premature ventricular contractions arising from the papillary muscles and the fascicular system. Echocardiography can identify MVP and mitral annular disjunction, a feature that has significant negative prognostic value in MVP. Cardiac MRI is indicated for identifying fibrosis. Patients with high-risk features should be referred for further evaluation. Catheter ablation and mitral valve repair might reduce the risk of malignant arrhythmia. MVP patients with high-risk features and clinically documented ventricular arrhythmia may also be considered for an ICD.
二尖瓣脱垂(MVP)是一种常见病症,在1%至3%的人群中存在。有证据表明,一部分MVP患者发生心源性猝死的风险更高。心律失常机制与脱垂瓣膜导致的乳头肌纤维化改变有关。心电图特征包括下壁导联ST段压低、T波倒置或双向T波,以及源自乳头肌和束支系统的室性早搏。超声心动图可识别MVP和二尖瓣环分离,这一特征在MVP中具有显著的不良预后价值。心脏磁共振成像用于识别纤维化。具有高危特征的患者应转诊作进一步评估。导管消融和二尖瓣修复可能会降低恶性心律失常的风险。具有高危特征且有临床记录的室性心律失常的MVP患者也可考虑植入植入式心律转复除颤器(ICD)。